Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC

Clinical trial NCT06694129 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06694129
Sponsor: National Cancer Center, China
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer ROS1 Gene Rearrangement Resistance Targeted Therapy

Start date: 2024-12-01
Primary completion: 2026-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.